111 related articles for article (PubMed ID: 3773883)
1. Mechanisms of in vitro pyrrole adduct autoxidation in 2,5-hexanedione-treated protein.
DeCaprio AP
Mol Pharmacol; 1986 Nov; 30(5):452-8. PubMed ID: 3773883
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of formation and quantitation of imines, pyrroles, and stable nonpyrrole adducts in 2,5-hexanedione-treated protein.
DeCaprio AP; Jackowski SJ; Regan KA
Mol Pharmacol; 1987 Oct; 32(4):542-8. PubMed ID: 3312999
[TBL] [Abstract][Full Text] [Related]
3. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure.
DeCaprio AP; O'Neill EA
Toxicol Appl Pharmacol; 1985 Apr; 78(2):235-47. PubMed ID: 3929425
[TBL] [Abstract][Full Text] [Related]
4. Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein.
Zhu M; Spink DC; Yan B; Bank S; DeCaprio AP
Chem Res Toxicol; 1994; 7(4):551-8. PubMed ID: 7981420
[TBL] [Abstract][Full Text] [Related]
5. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat.
DeCaprio AP; Briggs RG; Jackowski SJ; Kim JC
Toxicol Appl Pharmacol; 1988 Jan; 92(1):75-85. PubMed ID: 3341029
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 2,5-hexanedione-induced protein cross-linking by biological thiols: chemical mechanisms and toxicological implications.
Zhu M; Spink DC; Yan B; Bank S; DeCaprio AP
Chem Res Toxicol; 1995; 8(5):764-71. PubMed ID: 7548760
[TBL] [Abstract][Full Text] [Related]
7. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking.
Anthony DC; Boekelheide K; Anderson CW; Graham DG
Toxicol Appl Pharmacol; 1983 Dec; 71(3):372-82. PubMed ID: 6658787
[TBL] [Abstract][Full Text] [Related]
8. Comparative covalent protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat.
DeCaprio AP; Kinney EA; LoPachin RM
J Toxicol Environ Health A; 2009; 72(14):861-9. PubMed ID: 19557614
[TBL] [Abstract][Full Text] [Related]
9. Evidence that pyrrole formation is a pathogenetic step in gamma-diketone neuropathy.
Genter MB; Szakál-Quin G; Anderson CW; Anthony DC; Graham DG
Toxicol Appl Pharmacol; 1987 Feb; 87(2):351-62. PubMed ID: 3103260
[TBL] [Abstract][Full Text] [Related]
10. Novel 2,5-hexanedione analogues. Substituent-induced control of the protein cross-linking potential and oxidation susceptibility of the resulting primary amine-derived pyrroles.
Xu G; Singh MP; Gopal D; Sayre LM
Chem Res Toxicol; 2001 Mar; 14(3):264-74. PubMed ID: 11258975
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity and protein binding of 2,5-hexanedione in the hen.
DeCaprio AP; Strominger NL; Weber P
Toxicol Appl Pharmacol; 1983 Apr; 68(2):297-307. PubMed ID: 6857666
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formation.
Sayre LM; Shearson CM; Wongmongkolrit T; Medori R; Gambetti P
Toxicol Appl Pharmacol; 1986 Jun; 84(1):36-44. PubMed ID: 3715867
[TBL] [Abstract][Full Text] [Related]
13. The role of pyrrole formation in the alteration of neurofilament transport induced during exposure to 2,5-hexanedione.
Pyle SJ; Amarnath V; Graham DG; Anthony DC
J Neuropathol Exp Neurol; 1992 Jul; 51(4):451-8. PubMed ID: 1619444
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament protein crosslinking in gamma-diketone neuropathy: in vitro and in vivo studies using the seaworm myxicola infundibulum.
St Clair MB; Anthony DC; Wikstrand CJ; Graham DG
Neurotoxicology; 1989; 10(4):743-56. PubMed ID: 2562540
[TBL] [Abstract][Full Text] [Related]
15. Solid-state 13C-NMR spectroscopy of adduction products of 2,5-hexanedione with ribonuclease, albumin, and rat neurofilament protein.
Yan B; DeCaprio AP; Zhu M; Bank S
Chem Biol Interact; 1996 Oct; 102(2):101-16. PubMed ID: 8950225
[TBL] [Abstract][Full Text] [Related]
16. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
Graham DG; Anthony DC; Szakál-Quin G; Gottfried MR; Boekelheide K
Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
[TBL] [Abstract][Full Text] [Related]
17. Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy.
Genter St Clair MB; Amarnath V; Moody MA; Anthony DC; Anderson CW; Graham DG
Chem Res Toxicol; 1988; 1(3):179-85. PubMed ID: 2979729
[TBL] [Abstract][Full Text] [Related]
18. Cross-linking of proteins by 3-(trifluoromethyl)-2,5-hexanedione. Model studies implicate an unexpected amine-dependent defluorinative substitution pathway competing with pyrrole formation.
Xu G; Sayre LM
J Org Chem; 2002 May; 67(9):3007-14. PubMed ID: 11975560
[TBL] [Abstract][Full Text] [Related]
19. Alternative biomarkers of n-hexane exposure: characterization of aminoderived pyrroles and thiol-pyrrole conjugates in urine of rats exposed to 2,5-hexanedione.
Torres ME; Gonçalves LL; Bronze MR; dos Santos AP; Batoréu MC; Mateus ML
Toxicol Lett; 2014 Jan; 224(1):54-63. PubMed ID: 24459702
[TBL] [Abstract][Full Text] [Related]
20. Hyperbaric oxygen accelerates the neurotoxicity of 2,5-hexanedione.
Rosenberg CK; Anthony DC; Szakál-Quin G; Genter MB; Graham DG
Toxicol Appl Pharmacol; 1987 Feb; 87(2):374-9. PubMed ID: 3824391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
